Global Sexual Health Partnering Deal Trends, Players and Financials Report 2012-2018

Dublin, March 09, 2018 -- The "Global Sexual Health Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Sexual Health Partnering 2012 to 2018 provides the full collection of Sexual Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Sexual Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sexual Health deals.

The report presents financial deal terms values for Sexual Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Sexual Health partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Report scope

Global Sexual Health Partnering 2012 to 2018 includes:

• Trends in Sexual Health dealmaking in the biopharma industry since 2012
• Analysis of Sexual Health deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Sexual Health deal contract documents
• Comprehensive access to over 3500 Sexual Health deal records
• The leading Sexual Health deals by value since 2012
• Most active Sexual Health dealmakers since 2012
  

Available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Sexual Health dealmaking

Chapter 3 - Financial deal terms for Sexual Health partnering

Chapter 4 - Leading Sexual Health deals and dealmakers

Chapter 5 - Sexual Health contract document directory

Chapter 6 - Sexual Health dealmaking by therapeutic target

For more information about this report visit https://www.researchandmarkets.com/research/qrzn88/global_sexual?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Sexual and Reproductive Health Drugs